Redaporfin
Redaporfin (F-2BMet/LUZ-11) is a photosensitizer for cancer photodynamic therapy (PDT) . In preclinical studies, vascular-targeted PDT with redaporfin induced complete regression of subcutaneous CT26 colon tumors in 83% of treated mice. Its application extends to research in oncology, investigating both in vivo antitumor efficacy and in vitro photobiological mechanisms.
Product Specifications
CAS Number
1224104-08-8
Field of Research
Immunology & Inflammation, Metabolism Research, Signal Transduction
Smiles
CNS (=O) (=O) c1ccc (F) c (c1F) -c1c2CCc (n2) c (-c2c (F) ccc (c2F) S (=O) (=O) NC) c2ccc ([nH]2) c (c2CCc (n2) c (-c2c (F) ccc (c2F) S (=O) (=O) NC) c2ccc1[nH]2) -c1c (F) ccc (c1F) S (=O) (=O) NC
Molecular Formula
C48H38F8N8O8S4
Molecular Weight
1135.11
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15353545 1 Vial
Lentiviral human TTR shRNA (UAS) - Lentiviral human TTR shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 
